2011 Publications

2011

Skinner TC, Carey ME, Cradock S, Dallosso HM, Daly H, Davies MJ, Doherty Y, Heller S, Khunti K, Oliver L, on behalf of the DESMOND Collaborative. Comparison of Illness Representations Dimensions and Illness Representation Clusters in Predicting Outcomes in the First Year Following Diagnosis of Type 2 Diabetes: Results from the DESMOND trial. Psychol Health. 2011 Mar; 26(3):321-35. PMID 20309775

Aujlia N, Davies M.J, Skinner T.C, Gray L.J, Webb D.R, Srinivasan B, Khunti K. The association between anxiety and measures of glycaemia in a population-based diabetes screening programme. Diabetic Medicine Jul 2011 28(7):785-8. PMID 21672003.

Webb D.R, Gray L.J, Khunti K, Campbell S, Dallosso H, Davies MJ. Contrasting cardiovascular risk profiles and prescribed cardio-protective therapies in newly-diagnosed type 2 diabetes identified through screening and standard practice. Diabetes Res Clin Pract 2011 Mar;91 (3):280-5. PMID 21194777

Benhalima K, Wilmot E, Khunti K, Gray L.J, Lawrence I, Davies M. Type 2 diabetes in younger adults: clinical characteristics, diabetes-related complications and management of risk factors. Primary Care Diabetes Apr 2011;5 (1):57-62. PMID 20851071

Holman RR, Zinman B, Yusuf S, Sheridan PM, Anand SS, Bosch JJ, Conget I, Davies MJ, Pirags V, Dagenais GR, Pogue JM, Zimmet PZ, Gerstein HC. Incidence of Diabetes Following Ramipril or Rosiglitazone Withdrawal. Diabetes Care, 2011 Jun;34(6):1265-9. PMID 21515846

Dunkley A, Davies MJ, Stone M, Taub N, Troughton J, Yates T, Khunti K. The Reversal Intervention for Metabolic Syndrome (TRIMS) study: rationale design, and baseline data. Trials, 2011 May 4; 12:107. PMID 21542913

Yates T, Wilmot EG, Davies MJ, Gorely T, Edwardson C, Biddle S, Khunti K. Sedentary Behaviour, what’s in a Definition? American Journal of Preventive Medicine, 2011 Jun:40(6):e33-4. PMID 21565646

Webb DR, Gray LJ, Khunti K, Srinivasan B, Taub N, Campbell S, Barnett J, Farooqi A Echouffo-Tcheuqui JB, Griffin SJ, Wareham NJ, Davies MJ. Screening for diabetes using an oral glucose tolerance test within a western multi-ethnic population identifies modifiable cardiovascular risk: the ADDITION-Leicester study. Diabetologia 2011 Sep;54(9):2237-46. PMID 21638133

Crasto W, Jarvis J, Khunti K, Skinner TC, Gray LJ, Brela J, Troughton J, Daly H, Lawrence IG, McNally PG, Carey ME, Davies MJ. Multifactorial intervention in individuals with type 2 diabetes and microalbuminuria: The Microalbuminuria Education and Medication Optimisation (MEMO) study. Diabetes Research and Clinical Practice, 2011 Sep;93(3):328-36 PMID 21640424

Van Den Donk M, Sandbaek A, Borch-Johnsen K, Lauritzen T, Simmons RK, Wareham NJ, Griffin SJ, Davies MJ, Khunti K, Rutten GE. Screening for Type 2 diabetes. Lessons from the ADDITION-Europe study. Diabet Med, 2011 Nov;28(11):1416-1424. PMID 21679235

Griffin SJ, Borch-Johnsen K, Davies MJ, Khunti K, Rutten G, Sandbaek A, Sharp SJ, Simmons RK, Van Den Donk M, Wareham NJ, Lauritzen T. Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by the screening (ADDITION-Europe): a cluster-randomised trial. Lancet, 2011 Jul 9;378(9786):156-67. PMID 21705063

Yates T, Davies MJ, Sehmi S, Gorely T, Khunti K. The Pre-diabetes Risk Education and Physical Activity Recommendation and Encouragement (PREPARE) programme study: are improvements in glucose regulation sustained at 2 years? Diabet Med 2011 Oct;28(10):1268-71. PMID 21672008

Mehta RL, Davies MJ, Mli S, Taub NA, Stone MA, Baker R, McNally PG, Lawrence IG, Khunti K. Association of cardiac and non-cardiac chronic disease co-morbidity on glycaemic control in a multi-ethnic population with Type 1 and Type 2 diabetes. Postgrad Med J. 2011 Nov;87(1033):763-8 PMID 21873464

Davies M.J, Pratley R, Hammer M, Thomsen AB, Cuddihy R. Liraglutide improves treatment satisfaction in people with Type 2 diabetes compared with sitagliptin, each as an add on to metformin. Diabetic Med, Mar 2011;28(3):333-7. PMID 21309842

Kela R, Davies MJ. GLP-1 Analogue Liraglutide – review of its efficacy and role in management of type 2 diabetes. Int J Clin Rev 2011;10:11

Yates T, Wlimot EG, Khunti K, Biddle S, Gorely T, Davies MJ. Stand up for your health: Is it time to rethink the physical activity paradigm? Diabetes Res Clin Pact. 2011 Aug;93(2):292-4. PMID 21507499

Pratley R, Nauck M, Bailey T, Montanya E, Cuddihy R, Filetti S, Garber A, Thomsen AB, Hartvig H, Davies M, 1860-LIRA-DPP-4 Study Group. One year of liraglutide treatment offers sustained and more effective glycaemic control and weight reduction compared with sitagliptin, both in combination with metformin, in patients with type 2 diabetes: a randomised, parallel-group, open-label trial. Int J Clin Pract. 2011 Apr;65(4):397-407 PMID 21355967

Davies MJ, Kela R, Khunti. Liraglutide – overview of the preclinical and clinical data and its role in the treatment of type 2 diabetes. Diabetes Obes Metab. 2011 Mar;12(3):207-20. PMID 21205109

Gholap N, Davies M, Patel K, Sattar N, Khunti K. Type 2 diabetes and cardiovascular disease in south asians. Prim Care Diabetes. 2011 Apr;5(1):45-46. PMID 20869934

Gray L, Yates T, Davies MJ, Brady E, Webb D, Sattar N, Khunti K. Defining Obesity Cut-Off Points for Migrant South Asians. PLoS One. 2011;6(10):e26464. Epub. PMID 22039493

Khunti K, Davies MJ. Exenatide once weekly in the management of Type 2 Diabetes. Diabetes & Primary Care 2011 Vol 13 No 4.

Yates T, Davies MJ, Schwarz PE, Khunti K. Diabetes prevention: A call to action. Indian J Med Res. 2011 Nov;134(5):579-82. PMID 22199093

T Henry R, Buse J, Sesti G, Davies MJ, Jensen K, Brett J, Pratley RE. The efficacy of anti-hyperglycemic therapies and the influence of baseline A1C: a meta-analysis of the liraglutide development program. Endocr Pract. 2011 Nov 1; 17(6):906-13. PMID 22193143

Kela R, Khunti K, Davies MJ. Liraglutide for Type 2 diabetes mellitus. Expert Opin Biol Ther. 2011 Jul;11(7):951-9. PMID 21563859

Benhalima K, Song SH, Wilmot EG, KK, LG, Lawrence I, Davies MJ. Characteristics, complications and management of a large multiethnic cohort of younger adults with type 2 diabetes. Primary Care Diabetes 2011;5:245-250. PMID 21782538

Crasto W, Khunti K, Davies MJ. An Update on exenatide – a novel therapeutic option for patients with type 2 diabetes. Drugs of Today 2011;47(11):839-856. PMID 22146227

Mostafa S,Khunti K, Srinivasan BT, Webb D, Davies MJ. Detecting type 2 diabetes and impaired glucose regulation using glycated haemoglobin in different populations. Diabetes Management 2011;1(1)77-97.

Patel N, Eborall H, Khunti K, Davies MJ, Stone MA. Disclosure of type 1 diabetes status: a qualitative study in a mixed South Asian population in central England. Diversity in Health and Care. 2011;8:217-23.

Tarigopula G, Davies MJ. Pharmacological control of blood sugar. Anaesthesia & Intensive Care Med 2011; (12)11:473-475.

Wilmot E, Edwardson C, Gorely T, Khunti K, Nimmo M, Yates T, Biddle SJH. Rationale and study design for a randomised controlled trial to reduce sedentary time in adults at risk of type 2 diabetes mellitus: Project STAND (Sedentary Time ANd Diabetes). BMC Public Health. 2011 Dec 8;11:908. PMID 22151909

Davies MJ. The NICE Diabetes in Adults Quality Standards. The British Journal of Diabetes and Vascular Medicine 2011, 11(5):225-227

Back to top

To main page

Share this page: